The impact of rosuvastatin on inflammatory markers in L-NAME induced hypertensive rats
Background and objective: Many clinical trials have revealed that HMG-CoA reductase inhibitors (statins) have anti-inflammatory effects through their pleiotropic activities there by decreasing the risk of cardiovascular disease (CVD). This study intended to evaluate the effect of rosuvastatin on the...
Main Authors: | Kawa F. Dizaye, Begard O. Berzinji |
---|---|
Format: | Article |
Language: | English |
Published: |
Hawler Medical University
2023-04-01
|
Series: | Zanco Journal of Medical Sciences |
Subjects: | |
Online Access: | https://zjms.hmu.edu.krd/index.php/zjms/article/view/892 |
Similar Items
-
Investigating the effect of Fenofibrate on biomarkers of vascular inflammation in L-NAME induced hypertensive rats
by: Begard Berzinji, et al.
Published: (2022-05-01) -
Rosuvastatin, Sildenafil and Their Combination in Monocrotaline-Induced Pulmonary Hypertension in Rat
by: Jasińska-Stroschein Magdalena, et al.
Published: (2014-09-01) -
Magnesium Sulfate, Rosuvastatin, Sildenafil and Their Combination in Chronic Hypoxia-Induced Pulmonary Hypertension in Male Rats
by: Silvana-Elena Hojda, et al.
Published: (2024-09-01) -
Rosuvastatin-Induced reversible rhabdomyolysis
by: Sangeeta Pradhan, et al.
Published: (2023-01-01) -
Rosuvastatin induced photolocalized purpura
by: Marwa Thabouti, et al.
Published: (2022-09-01)